These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16968365)

  • 1. Treatment costs and clinical outcome for first episode schizophrenia patients: a 3-year follow-up of the Swedish "Parachute Project" and two comparison groups.
    Cullberg J; Mattsson M; Levander S; Holmqvist R; Tomsmark L; Elingfors C; Wieselgren IM
    Acta Psychiatr Scand; 2006 Oct; 114(4):274-81. PubMed ID: 16968365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of care of schizophrenia: a study of Indian out-patient attenders.
    Grover S; Avasthi A; Chakrabarti S; Bhansali A; Kulhara P
    Acta Psychiatr Scand; 2005 Jul; 112(1):54-63. PubMed ID: 15952946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care resource use associated with integrated psychological treatment.
    Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
    J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan.
    Gau SS; Chung CH; Gau CS
    J Clin Psychopharmacol; 2008 Jun; 28(3):271-8. PubMed ID: 18480683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Preliminary results.
    Agius M; Shah S; Ramkisson R; Murphy S; Zaman R
    Psychiatr Danub; 2007 Jun; 19(1-2):10-9. PubMed ID: 17603411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating intensive psychosocial therapy and low dose medical treatment in a total material of first episode psychotic patients compared to "treatment as usual" a 3 year follow-up.
    Cullberg J
    Med Arh; 1999; 53(3):167-70. PubMed ID: 10546453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of the costs of treating schizophrenia in Spain: a hierarchical Bayesian approach.
    Vázquez-Polo FJ; Negrín M; Cabasés JM; Sánchez E; Haro JM; Salvador-Carulla L
    J Ment Health Policy Econ; 2005 Sep; 8(3):153-65. PubMed ID: 16278503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient vs. comprehensive first-episode psychosis services, a 5-year follow-up of Soteria Nacka.
    Lindgren I; Falk Hogstedt M; Cullberg J
    Nord J Psychiatry; 2006; 60(5):405-9. PubMed ID: 17050299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
    Marcus SC; Olfson M
    Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: economics.
    Fitzgerald PB; Montgomery W; de Castella AR; Filia KM; Filia SL; Christova L; Jackson D; Kulkarni J
    Aust N Z J Psychiatry; 2007 Oct; 41(10):819-29. PubMed ID: 17828655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of outcome in first-episode schizophrenia over the first 4 years of illness.
    Whitty P; Clarke M; McTigue O; Browne S; Kamali M; Kinsella A; Larkin C; O'Callaghan E
    Psychol Med; 2008 Aug; 38(8):1141-6. PubMed ID: 18447960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of treating first-episode psychosis: five-year follow-up results from an Italian early intervention programme.
    Cocchi A; Mapelli V; Meneghelli A; Preti A
    Early Interv Psychiatry; 2011 Aug; 5(3):203-11. PubMed ID: 21729243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-site Canadian perspective: examining the functional outcome from first-episode psychosis.
    Menezes NM; Malla AM; Norman RM; Archie S; Roy P; Zipursky RB
    Acta Psychiatr Scand; 2009 Aug; 120(2):138-46. PubMed ID: 19207130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation.
    Startup M; Jackson MC; Evans KE; Bendix S
    Psychol Med; 2005 Sep; 35(9):1307-16. PubMed ID: 16168153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-episode psychosis: an epidemiological survey comparing psychotic depression with schizophrenia.
    Crebbin K; Mitford E; Paxton R; Turkington D
    J Affect Disord; 2008 Jan; 105(1-3):117-24. PubMed ID: 17574683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of mental health care cost units for patients with schizophrenia.
    Saldivia Bórquez S; Torres González F; Cabasés Hita JM;
    Actas Esp Psiquiatr; 2005; 33(5):280-5. PubMed ID: 16155809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of schizophrenia during 5 years.
    Lindström E; Eberhard J; Neovius M; Levander S
    Acta Psychiatr Scand Suppl; 2007; (435):33-40. PubMed ID: 17953524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.